Cryoport (CYRX) closed at $20.56 on November 11, 2026, down 0.9% from the previous close, on volume of 903,246 shares (30-day average 1,103,934).
Data as of November 11, 2026.
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Oct 22, 2026 | Diagonal Call Spread | 18-Dec-26 : 15-Jan-277.5 : 10 C | 2,500 |
| 2-3 | The next 2 largest trades are for Premium members. Start a 7-day free trial | |||
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 10, 2026. See the 10 largest for 30, 60 and 90 days
Cryoport Reports Third Quarter 2026 Financial Results
PRNewswire (Thu, 5-Nov 4:05 PM ET)
Cryoport to Report Third Quarter 2026 Financial Results on November 5, 2026
PRNewswire (Thu, 22-Oct 8:00 AM ET)
Cryoport Lifts Revenue Guidance After Strong Q1—Expansion in Cell & Gene Therapy Drives Growth
Market Chameleon (Tue, 5-May 7:11 AM ET)
CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.
Cryoport trades on the NASDAQ stock market under the symbol CYRX.
As of November 11, 2026, CYRX stock price declined to $20.56 with 903,246 million shares trading.
CYRX has a beta of 1.39, meaning it tends to be more sensitive to market movements. CYRX has a correlation of 0.12 to the broad based SPY ETF.
CYRX has a market cap of $1.04 billion. This is considered a Small Cap stock.
Last quarter Cryoport reported $50 million in Revenue and -$.25 earnings per share. This beat revenue expectation by $2 million and missed earnings estimates by -$.07.
In the last 3 years, CYRX traded as high as $21.78 and as low as $4.58.
The top ETF exchange traded funds that CYRX belongs to (by Net Assets): IWM, VTI, VXF, IWN, DFAS.
CYRX has outperformed the market in the last year with a price return of +140.7% while the SPY ETF gained +12.6%. CYRX has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +38.7% and +11.7%, respectively, while the SPY returned -1.5% and -1.3%, respectively.
CYRX support price is $19.96 and resistance is $21.52 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CYRX shares will trade within this expected range on the day.
